This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets.
Diet, Life Style, Smoking.- Blood Pressure Lowering.- Glycemic Control in Diabetes.- LDL-Cholesterol Lowering.- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation).- Triglyceride Rich Lipoproteins.- HDL.- Lipoprotein(a).- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome.- Nutraceuticals / Functional Food.- Adipose Tissue (WAT, BAT).- Microbiota and Cardiometabolic Disease.- SMCs, Matrix.- Immune Modulation.- NETs and Neutrophils.- Genomic Strategies Towards Identification of Novel Therapeutic Targets.- Non Coding RNAs.- Metabolomics, Lipidomics.- Epigenomics.
Previous publications in the Handbook of Experimental Pharmacology series co-edited by Prof. Arnold von Eckardstein : Atherosclerosis: Diet and Drugs, 2005, Arnold von Eckardstein; High Density Lipoproteins, 2015, Arnold von Eckardstein, Dimitris Kardassis (eds.), Open Access
